ImmunoCellular Therapeutics Ltd Stock Forecast
ImmunoCellular Therapeutics Ltd stock upgraded to Hold/Accumulate.
(Updated on Apr 24, 2024)
No changes to the price of ImmunoCellular Therapeutics Ltd stock on the last trading day (Wednesday, 24th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $0.198 to a day high of $0.198. The price has risen in 4 of the last 10 days and is up by 30.39% over the past 2 weeks.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.206 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -50.74% during the next 3 months and, with a 90% probability hold a price between $0.0261 and $0.101 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
IMUC Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ImmunoCellular Therapeutics Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.204. On a fall, the stock will find some support from the short-term average at $0.188. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for ImmunoCellular Therapeutics Ltd stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.183 and $0.152. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ImmunoCellular Therapeutics Ltd finds support just below today's level at $0.183. If this is broken, then the next support from accumulated volume will be at $0.152 and $0.152.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 6.42%
Our recommended stop-loss: $0.190 (-4.00%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (IMUC) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect ImmunoCellular Therapeutics Ltd to open at $0.198, and during the day (based on 14 day Average True Range), to move between $0.155 and $0.241, which gives a possible trading interval of +/-$0.0429 (+/-21.70%) up or down from last closing price. If ImmunoCellular Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 43.39% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.183 (7.53%) than the resistance at $0.219 (10.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is ImmunoCellular Therapeutics Ltd stock A Buy?
ImmunoCellular Therapeutics Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.000 Hold/Accumulate Upgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Opening Price for ImmunoCellular Therapeutics Ltd of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $0.198 ( 0%) | $0.198 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for IMUC
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.198 | . | |
| R2 | 0.198 | . | ||
| R1 | 0.198 | . | ||
| Current price: | 0.198 | |||
| Support | S1 | 0.198 | . | |
| S2 | 0.198 | . | ||
| S3 | 0.198 | . |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.240 | 21.27 % | |
| R2 | 0.230 | 16.22 % | ||
| R1 | 0.219 | 10.61 % | ||
| Current price | 0.198 | |||
| Support | S1 | 0.183 | -7.53% | |
| S2 | 0.152 | -23.19% | ||
| S3 | 0.152 | -23.31% |
FAQ
Click here for our free guide on how to buy ImmunoCellular Therapeutics Ltd Stock.
